Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
17.75
-0.01 (-0.06%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Crescent Biopharma Employees
Crescent Biopharma had 69 employees as of June 30, 2026. The number of employees increased by 36 or 109.09% compared to the same quarter last year.
Employees
69
Change
36
Growth
109.09%
Revenue / Employee
$172,217
Profits / Employee
-$2,393,101
Market Cap
759.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 69 | 36 | 109.09% |
| Mar 31, 2026 | 55 | 22 | 66.67% |
| Dec 31, 2025 | 44 | - | - |
| Sep 30, 2025 | 41 | - | - |
| Jun 30, 2025 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Neurogene | 131 |
| Aura Biosciences | 113 |
| Silence Therapeutics | 88 |
| BridgeBio Oncology Therapeutics | 88 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
| Shattuck Labs | 40 |
| Bright Minds Biosciences | 26 |
CBIO News
- 26 days ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 4 weeks ago - Crescent Biopharma reports Q2 EPS (74c), consensus (64c) - TheFly
- 4 weeks ago - Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 4 weeks ago - Crescent Biopharma Earnings release: Q2 2026 - Filings
- 4 weeks ago - Crescent Biopharma Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 6 weeks ago - Crescent Biopharma 8.095M share Spot Secondary priced at $14.50 - TheFly
- 6 weeks ago - Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire